文献速递产科母胎医学

QUiPP App v.2 工具对就诊早产专科门诊的无症状高危孕妇早产预测性能:外部验证研究

Performance of QUiPP App v.2 tool for prediction of preterm birth in asymptomatic high-risk women attending preterm specialist clinic: external validation study.
PubMed 文献 · Ultrasound Obstet Gynecol · 2024-06-15

在爱尔兰一家早产监测门诊对762名无症状高危孕妇的1660次就诊进行回顾性单中心观察研究,外部验证QUiPP App v.2的区分度和校准度。该工具对短期早产结局区分度较好,对37周前早产的区分度较低;低风险者校准良好,高风险者预测概率高于实际发生率。

要点

  • QUiPP App v.2对1周内早产区分度最高(AUC 0.866),对37周前早产区分度较低(AUC 0.631)。
  • 低风险结果校准良好,高风险孕妇预测概率超过实际早产发生率,可能存在「治疗悖论」。
  • 作者认为需进一步研究接受预防性治疗的孕妇中QUiPP治疗阈值能否安全调整。

核心结论

  • QUiPP App v.2能准确区分短期早产风险的孕妇。
  • 高风险孕妇中可能存在「治疗悖论」影响校准。
  • 需进一步研究接受预防性治疗的孕妇中QUiPP治疗阈值能否安全调整以及是否改善结局。

研究设计与样本

  • 回顾性、单中心、观察性研究,评估QUiPP App v.2在六个预设临床时间点的区分度和校准度。
  • 研究纳入2019年至2022年间使用QUiPP App v.2的762名孕妇共1660次早产监测门诊就诊。
  • 研究人群包括142名(18.6%)后来发生早产的孕妇。

主要发现

  • 1周内分娩AUC为0.866(95% CI 0.755-0.955),2周内分娩AUC为0.721(95% CI 0.569-0.854),4周内分娩AUC为0.775(95% CI 0.699-0.842)。
  • 30周前分娩AUC为0.747(95% CI 0.613-0.865),37周前早产AUC为0.631(95% CI 0.596-0.668)。
  • 低风险结果校准总体良好,预测风险与观察发生率趋于一致。
  • 被评估为早产风险较高的孕妇中,预测概率超过实际早产发生率。

关键数值与推荐

  • 区分度通过受试者工作特征曲线下面积(AUC)及固定假阳性率5%、10%、20%下的敏感度评估。
  • 校准度通过评估预期结局与观察结局的一致性来评价。
  • P值<0.05视为有统计学显著性。
  • 未对治疗效果进行调整。

局限性

  • 本研究为回顾性、单中心、观察性研究。
  • 未对治疗效果进行调整。
  • 需进一步研究以确定接受预防性治疗的孕妇中QUiPP治疗阈值能否安全调整以及是否改善结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To validate externally the QUiPP App v.2 algorithms in an independent cohort of high-risk asymptomatic women attending a preterm birth (PTB) surveillance clinic in Ireland. METHODS: This was a retrospective, single-center, observational study assessing discrimination and calibration of the QUiPP App v.2 at six predetermined clinical timepoints (PTB at < 30, < 34 and < 37 weeks of pregnancy and PTB within 1, 2 and 4 weeks of testing). Discrimination was assessed by estimating the area under the receiver-operating-characteristics curve (AUC) and sensitivity at fixed false-positive rates of 5%, 10% and 20%. Model calibration was assessed to evaluate the concordance between expected and observed outcomes. P-values < 0.05 were considered statistically significant. No adjustments for treatment effects were made. RESULTS: Overall, 762 women with 1660 PTB surveillance clinic visits using the QUiPP App v.2 between 2019 and 2022 were analyzed. The study population included 142 (18.6%) patients who later experienced PTB. The QuiPP App's performance in the prediction of short-term outcomes, such as birth within 1 week (AUC, 0.866 (95% CI, 0.755-0.955)), 2 weeks (AUC, 0.721 (95% CI, 0.569-0.854)) and 4 weeks (AUC, 0.775 (95% CI, 0.699-0.842)), and delivery at < 30 weeks (AUC, 0.747 (95% CI, 0.613-0.865)), was superior to its ability to predict longer-term outcomes (PTB at < 37 weeks: AUC, 0.631 (95% CI, 0.596-0.668)). Calibration was generally good for low-risk results, as the predicted risk in these patients tended to match the observed incidence. However, in women deemed to be at greater risk of PTB, the predicted probability superseded the observed incidence of PTB. CONCLUSIONS: The QUiPP App v.2 accurately discriminates women who are at short-term risk of PTB. A 'treatment paradox' may influence calibration in high-risk women. Further research is needed to ascertain if QuiPP treatment thresholds can be safely adjusted in women receiving prophylactic treatment to prevent PTB, and whether this improves the outcome. © 2024 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Creswell L, Rolnik DL, Burke B, et al. Performance of QUiPP App v.2 tool for prediction of preterm birth in asymptomatic high-risk women attending preterm specialist clinic: external validation study. Ultrasound Obstet Gynecol. 2024. PMID: 38379428. doi:10.1002/uog.27619

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。